---
figid: PMC6695603__ijms-20-03821-g003
figtitle: EGFR pathway regulates PD-L1 expression in NSCLC
organisms:
- NA
organisms_ner:
- Homo sapiens
pmcid: PMC6695603
filename: ijms-20-03821-g003.jpg
figlink: /pmc/articles/PMC6695603/figure/ijms-20-03821-f003/
number: F3
caption: The EGFR pathway regulates PD-L1 expression in NSCLC. Stimulation of EGF
  or activation of EGFR kinase domain induced PD-L1 expression may be through the
  activating Hippo/yes-associated protein (YAP) signaling pathway in human NSCLC cells.
  Inhibition of EGFR by EGFR-TKIs downregulates PD-L1 expression in human EGFR-driven
  NSCLC cells.
papertitle: Epidermal Growth Factor Receptor (EGFR) Pathway, Yes-Associated Protein
  (YAP) and the Regulation of Programmed Death-Ligand 1 (PD-L1) in Non-Small Cell
  Lung Cancer (NSCLC).
reftext: Ping-Chih Hsu, et al. Int J Mol Sci. 2019 Aug;20(15):3821.
year: '2019'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9725766
figid_alias: PMC6695603__F3
figtype: Figure
redirect_from: /figures/PMC6695603__F3
ndex: 5ad2d354-debe-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6695603__ijms-20-03821-g003.html
  '@type': Dataset
  description: The EGFR pathway regulates PD-L1 expression in NSCLC. Stimulation of
    EGF or activation of EGFR kinase domain induced PD-L1 expression may be through
    the activating Hippo/yes-associated protein (YAP) signaling pathway in human NSCLC
    cells. Inhibition of EGFR by EGFR-TKIs downregulates PD-L1 expression in human
    EGFR-driven NSCLC cells.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - EGF
  - EGFR
  - MAPK1
  - MAPK3
  - MAPK11
  - MAPK12
  - MAPK13
  - MAPK14
  - MAPK8
  - MAPK9
  - MAPK10
  - YAP1
  - PDCD1
  - RPL17
  - RPL17-C18orf32
  - CD274
  - JUN
  - TEAD1
  - TEAD2
  - TEAD3
  - TEAD4
  - NSCLC tumor
---
